20/04/2026
We’d like to welcome new CMA member, Daiken Biomedical. Read a bit more about them below:
“Daiken Biomedical is a premier leader in the research and development of high-quality, high-purity dietary supplements. Originally established in Taiwan, Daiken has built a formidable presence across key Asian markets, including Taiwan and Japan. The company is dedicated to integrating rigorous scientific evidence with premium ingredients to provide modern consumers with truly effective health solutions. Our mission is to Family's peace, Future's health. By collaborating with top-tier global ingredient suppliers, Daiken ensures that every product—from formulation and clinical research to quality testing—adheres to the strictest international safety standards.
The Daiken team possesses a diverse range of backgrounds in medicine and nutritional science. Our expertise spans a wide portfolio, including high-concentration Omega-3 fish oil, vision-support lutein, and potent probiotics. As part of our global expansion strategy, Daiken Biomedical is currently actively preparing its entry into the Australian market. We aim to bridge our R&D capabilities from Asia with Australia’s sophisticated regulatory landscape for complementary medicines, introducing a competitive and diverse product range to Australian consumers while upholding the highest benchmarks of integrity and quality.”
Want to discover more about the benefits of CMA membership and learn how to join? Visit cmaustralia.org.au/membership